日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

免疫效应细胞相关噬血细胞性淋巴组织细胞增生症样综合征的临床和细胞因子特征。

Srinagesh Hrishikesh K, Kramer Anne Marijn, Baird John H, Reschke Agnes, Sahaf Bita, Cancilla Juancarlos, Syal Shriya, Su Yi-Jiun, Agarwal Neha, Jensen Alexandria M, Schultz Liora M, Jeyakumar Nikeshan, Ramakrishna Sneha, Davis Kara L, Dahiya Saurabh, Feldman Steven A, Mackall Crystal L, Muffly Lori S, Miklos David B, Frank Matthew J

Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel

放宽接受tisagenlecleucel治疗的低负担B细胞急性淋巴细胞白血病(B-ALL)患儿/青少年患者的医院就诊距离要求

Appell, Lauren E; Baggott, Christina; Nguyen, Khanh; Prabhu, Snehit; Pacenta, Holly; John, Samuel; Fabrizio, Vanessa A; Phillips, Christine L; Rossoff, Jenna; Talano, Julie-An; Moskop, Amy; Phelan, Rachel; Baumeister, Susanne H C; Verneris, Michael R; Hall, Erin M; Myers, Gary Douglas; Karras, Nicole A; Cooper, Stacy L; Qayed, Muna; Raikar, Sunil S; Winestone, Lena; Hermiston, Michelle; Satwani, Prakash; Krupski, Christa; Keating, Amy K; Friedman, Danielle N; Curran, Kevin J; Hoover, Alex; MacMillan, Margaret L; Ebens, Christen L; Ramgopal, Archana; Rahrig, April L; Mackall, Crystal L; Laetsch, Theodore W; McNerney, Kevin; Schultz, Liora M

Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies

CD22 CAR T 细胞治疗 B 细胞急性淋巴细胞白血病 (B-ALL) 的疗效:两种生产策略的比较

Dreyzin, Alexandra; Kramer, Anne Marijn; Yates, Bonnie; Wang, Hao-Wei; Sahaf, Bita; Yuan, Constance; Klysz, Dorota; Tunuguntla, Ramya; Ehlinger, Zachary; Reitberg, Skyler; Adebola, Serifat; Su, Angela; Ebina-Shibuya, Risa; Jia, Dongya; Achar, Sooraj; Patil, Sunita; Martin, Kathryn; Jeyakumar, Nikeshan; Davis, Kara L; Fry, Terry; Mackall, Crystal L; Taylor, Naomi; Altan-Bonnet, Gregoire; Highfill, Steven; Feldman, Steven; Stroncek, David F; Chien, Christopher; Schultz, Liora Michal; Frank, Matthew J; Muffly, Lori S; Shalabi, Haneen; Ramakrishna, Sneha; Shah, Nirali N

Immunotherapy-related cognitive impairment after CAR T cell therapy in mice

小鼠接受CAR-T细胞疗法后出现免疫疗法相关的认知障碍

Geraghty, Anna C; Acosta-Alvarez, Lehi; Rotiroti, Maria C; Dutton, Selena; O'Dea, Michael R; Kim, Wonju; Trivedi, Vrunda; Mancusi, Rebecca; Shamardani, Kiarash; Malacon, Karen; Woo, Pamelyn J; Martinez-Velez, Naiara; Pham, Theresa; Reche-Ley, Noemi N; Otubu, Gabriel; Castenada, Enrique H; Nwangwu, Kamsi; Xu, Haojun; Mulinyawe, Sara B; Zamler, Daniel B; Ni, Lijun; Cross, Kevin; Rustenhoven, Justin; Kipnis, Jonathan; Liddelow, Shane A; Mackall, Crystal L; Majzner, Robbie G; Monje, Michelle

IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies

IKAROS 水平与 CD19 和 CD22 靶向治疗 B 细胞恶性肿瘤中的抗原逃逸相关。

Domizi, Pablo; Sarno, Jolanda; Jager, Astraea; Merchant, Milton; Pacheco, Kaithlen Zen B; Yamada-Hunter, Sean A; Rotiroti, Maria Caterina; Liu, Yuxuan; Baskar, Reema; Reynolds, Warren D; Sworder, Brian J; Sahaf, Bita; Bendall, Sean C; Mullighan, Charles G; Alizadeh, Ash A; Leahy, Allison B; Myers, Regina M; Yates, Bonnie; Wang, Hao-Wei; Shah, Nirali N; Majzner, Robbie G; Mackall, Crystal L; Grupp, Stephan A; Barrett, David M; Sotillo, Elena; Davis, Kara L

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials

自体细胞基因疗法中人为引入异质性:首次人体试验的战略考量

Cabanski, Christopher R; Yang, EnJun; Stewart, Mark D; Allen, Jeff D; Connolly, John E; Dugan, Ute; Greenberg, Philip D; Mackall, Crystal L; June, Carl H; Marson, Alexander; Maus, Marcela V; Ribas, Antoni

Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recovery

通过灵活的生产和成本回收方式,实现对基因修饰细胞疗法的可及性。

Stewart, Mark D; Cabanski, Christopher R; Allen, Jeff D; Connolly, John E; Beneski, Ben M; Dropulić, Boro; Feldman, Steven A; Fleisher, Lee A; Hanley, Patrick J; Hege, Kristen; Kekre, Natasha; Fernandez Lynch, Holly; Mackall, Crystal L

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel

对接受tisagenlecleucel治疗的儿科患者进行特征分析和预测,以判断其是否出现持续性严重中性粒细胞减少症。

Naik, Swati; Selukar, Subodh; Talleur, Aimee C; Deshpande, Samira; Llaurador Caraballo, Gabriela; Fabrizio, Vanessa A; Rouce, Rayne H; Zeng, Xiaopei L; Vatsayan, Anant; Rossoff, Jenna; Pacenta, Holly L; John, Samuel; Phillips, Christine L; Talano, Julie-An; Moskop, Amy; Verneris, Michael R; Myers, Gary D; Hall, Erin; Karras, Nicole; Bonifant, Challice L; Qayed, Muna; Bakinowski, Emily; Keating, Amy K; Baumeister, Susanne H C; Tomilson, Emily; Hermiston, Michelle L; Satwani, Prakash; Krupski, Christa; Chinnabhandar, Vasant; Stefanski, Heather E; Egeler, Emily; Curran, Kevin J; Laetsch, Theodore W; Mackall, Crystal L; Prabhu, Snehit; Nguyen, Khanh P; Baggott, Christina; Schultz, Liora Michal; McNerney, Kevin O

A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors

一项针对表达 B7-H3 的复发或难治性实体瘤儿童和青少年患者的 Enoblituzumab I 期开放标签剂量递增研究

DeSantes, Kenneth B; McDowell, Kimberly A; Sondel, Paul M; Hutson, Paul R; Kaplan, Rosandra N; Park, Julie R; Hegde, Meenakshi G; Mackall, Crystal L; Maris, John M

Transcriptomic Diversity of Pediatric Acute Myeloid Leukemia Genetic Drivers Correlates With Clinical Outcome and Expression of Stemness-Related Genes

儿童急性髓系白血病遗传驱动因素的转录组多样性与临床结果和干性相关基因的表达相关

Bubb, Quenton Rashawn; Sotillo, Elena; Richards, Rebecca M; Mackall, Crystal L; Gruber, Tanja A; Czechowicz, Agnieszka